Clinical Trial Update: Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) [Phase 2]

View source ↗

Summary

Phase 2 results of zilebesiran as add-on therapy for hypertension not adequately controlled by standard antihypertensive medications were reported for the KARDI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Zilebesiran

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-07-09